Ohio Public Employees Retirement System (OPERS)
VIR icon

Ohio Public Employees Retirement System (OPERS)’s Vir Biotechnology VIR Stock Holding History

Ohio Public Employees Retirement System (OPERS)’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-112,700
Closed -$1.01M – 2388
2026
Q1 		$1.01M Buy
+112,700
New +$898K ﹤0.01% 1314
2025
Q1 		– Sell
-1,747
Closed -$12.8K – 2424
2024
Q4 		$12.8K Sell
1,747
-15,733
-90% -$124K ﹤0.01% 2287
2024
Q3 		$131K Buy
17,480
+459
+3% +$3.99K ﹤0.01% 1604
2024
Q2 		$151K Sell
17,021
-627
-4% -$6.01K ﹤0.01% 1393
2024
Q1 		$179K Sell
17,648
-409
-2% -$4.17K ﹤0.01% 1366
2023
Q4 		$182K Hold
18,057
– – ﹤0.01% 1388
2023
Q3 		$169K Buy
+18,057
New +$258K ﹤0.01% 1384

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SB Investment Advisers (UK)
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Ohio Public Employees Retirement System (OPERS)'s VIR Position: Q2 2026 in Review

Ohio Public Employees Retirement System (OPERS) sold out of Vir Biotechnology (VIR) in Q2 2026, closing a stake of 112,700 shares — an estimated $1.01M sold.

Ohio Public Employees Retirement System (OPERS) first reported a position in VIR in Q3 2023 and held it in 7 quarters. The position peaked at $1.01M in Q1 2026. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Ohio Public Employees Retirement System (OPERS) reported no remaining Vir Biotechnology position as of Q2 2026 after selling out during the quarter.
  • Ohio Public Employees Retirement System (OPERS) sold 112,700 Vir Biotechnology shares in Q2 2026, an estimated $1.01M.
  • Ohio Public Employees Retirement System (OPERS) first reported a position in Vir Biotechnology in Q3 2023 and held it in 7 quarters.
  • Ohio Public Employees Retirement System (OPERS)'s Vir Biotechnology position peaked at $1.01M in Q1 2026.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Ohio Public Employees Retirement System (OPERS)'s 13F filing for Q2 2026, filed 17 Aug 2026.